Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A biphasic opioid function modulator: agmatine.

Rui-Bin Su1, Jin Li, Bo-Yi Qin

  • 1Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

Acta Pharmacologica Sinica
|July 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroplastic alteration of TTX-resistant sodium channel with visceral pain and morphine-induced hyperalgesia.

Journal of pain research·2012
Same author

[Influences of D-galactosamine and lipopolysaccharide on liver tissue regeneration and repair in mice with partial hepatectomy].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2012
Same author

Large and giant ventral paraclinoid carotid aneurysms: surgical techniques, complications and outcomes.

Clinical neurology and neurosurgery·2012
Same author

Association of mitochondrial DNA variations with lung cancer risk in a Han Chinese population from southwestern China.

PloS one·2012
Same author

Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo.

Journal of radiation research·2012
Same author

Simultaneous determination of stilbenes, phenolic acids, flavonoids and anthraquinones in Radix polygoni multiflori by LC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2012
Same journal

Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies.

Acta pharmacologica Sinica·2026
Same journal

Targeting BCL9/BCL9L enhances CD4<sup>+</sup> T cell-mediated Th1 antitumor immunity through activation of STAT1/STAT4 signaling.

Acta pharmacologica Sinica·2026
Same journal

TGF-β2 signaling promotes cardiac fibrosis in arrhythmogenic right ventricular cardiomyopathy mediated by DSC2 deficiency.

Acta pharmacologica Sinica·2026
Same journal

Correction: Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.

Acta pharmacologica Sinica·2026
Same journal

Endothelial PARP1 orchestrates endothelial-to-mesenchymal transition via the PARylation of FHL2 in ischaemic heart failure.

Acta pharmacologica Sinica·2026
Same journal

Correction: Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling.

Acta pharmacologica Sinica·2026
See all related articles

New research identifies biphasic opioid function modulators (BOFMs) that enhance opioid analgesia while reducing tolerance and dependence. Agmatine is a key example, modulating opioid receptor signaling adaptation.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Discovery

Background:

  • Opioid receptor-independent agents modulate opioid drug actions.
  • Some agents exhibit biphasic effects: enhancing analgesia but inhibiting tolerance and dependence.

Purpose of the Study:

  • To define and identify agents with biphasic modulation of opioid functions, termed biphasic opioid function modulators (BOFMs).
  • To investigate agmatine as a representative BOFM and elucidate its mechanisms.

Main Methods:

  • Pharmacological assays to assess opioid receptor interaction.
  • Behavioral studies to evaluate analgesic effects, opioid tolerance, and dependence.
  • Analysis of opioid receptor signal transduction pathways.

Main Results:

Related Experiment Videos

  • Agmatine demonstrated weak intrinsic analgesia.
  • Agmatine significantly enhanced morphine analgesia.
  • Agmatine inhibited the development of opioid tolerance and dependence.

Conclusions:

  • Agmatine functions as a biphasic opioid function modulator (BOFM).
  • Agmatine's primary mechanism involves inhibiting opioid receptor signal transduction adaptation during chronic opioid exposure.
  • BOFMs represent a novel class of compounds for optimizing opioid therapy.